Gretchen Poland
Family · Overland Park, KSNPI 1033215538
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AstraZeneca at 24.3% of the total. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$668
- Sanofi$568
- Novartis$407
- CSL Behring$348
- GSK$335
- plus $3K from 27 others
What the payments were for
- Consulting fees$641%
- Food & beverage$7,15999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,758 |
| Regeneron Healthcare Solutions, Inc. | 24 | $668 |
| Sanofi | 20 | $568 |
| Novartis | 17 | $407 |
| CSL Behring | 16 | $348 |
| GSK | 15 | $335 |
| Boston Scientific | 14 | $331 |
| Amgen | 11 | $319 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $301 |
| Pharming Healthcare, Inc. | 16 | $299 |
| Genentech USA, Inc. | 16 | $279 |
| Hospira, Inc. | 14 | $239 |
| Grifols USA, LLC | 7 | $208 |
| LEO Pharma Inc. | 10 | $200 |
| Lilly USA, LLC | 5 | $161 |
| AbbVie | 7 | $126 |
| Incyte Corporation | 1 | $119 |
| Pfizer | 7 | $107 |
| Optinose US, Inc. | 3 | $65 |
| ADMA Biomanufacturing LLC | 4 | $64 |
| Octapharma USA, Inc. | 3 | $55 |
| Kaleo, Inc. | 2 | $42 |
| Boehringer Ingelheim | 2 | $30 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Biocryst US Sales Co., LLC | 1 | $22 |
| Seqirus USA Inc | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Cycle Pharmaceuticals Inc | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,223 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Kathryn TimmOverland Park$14K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
- Christopher PeltonOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.